Two University of Iowa faculty have received Donald D. Dorfman Research Award prizes for their published papers on leukemia research.
The award is granted through Holden Comprehensive Cancer Center at the University of Iowa to a member of the cancer center who has published the best paper on leukemia or lymphoma in a peer-reviewed journal in the previous year.
The $10,000 award customarily goes to one author, but because of the exceptional quality of this year’s submissions, the Dorfman family has generously funded two full prizes.
The award recipients are:
Miles A. Pufall, PhD, assistant professor of biochemistry, for publication of “Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.” Blood. 2017 Jun 1;129(22):3000–3008. doi: 10.1182/blood-2017-02-766204. Epub 2017 Apr 19. PubMed PMID: 28424165; PubMed Central PMCID: PMC5454339.
Hai-Hui “Howard” Xue, MD, PhD, professor of microbiology and immunology, for publication of “Prostaglandin E1 and its analog misoprostol inhibit human CML stem cell self-renewal via EP4 receptor activation and repression of AP-1.” Cell Stem Cell. 2017 Sep 7;21(3):359–373.e5. doi: 10.1016/j.stem.2017.08.001. Epub 2017 Aug 30. PubMed PMID: 28844837.
Related article: The Donald D. Dorfman research award doubles for 2017, The Daily Iowan